论文部分内容阅读
目前,中国已是世界第二大化学原料药生产和出口国——2002年中国化学原料药产量达56万吨,占世界化学原料药市场份额的22%,而同期中国化学原料药出口也达到了29.88亿美元。但是,随着市场全球化的进一步发展,以及世界原料药生产中心转移到亚洲,原料药销售在国际市场的竞争愈发激烈,中国原料药生产企业将面临更加严峻的考验。仅仅依靠传统的外贸包销制无法使国内原料药生产企业在国际竞争中取得成功。在传统的外贸包销制下,虽然一些企业的产品长期出口,但企业本身却不了解自己的产品在国际市场上如何运作,当然也更谈不上企业如何在国际市场中树立
At present, China is already the second largest producer and exporter of chemical raw materials in the world. In 2002, the output of chemical raw materials in China reached 560,000 tons, accounting for 22% of the world market for chemical raw materials, while the exports of Chinese chemical raw materials reached the same period 2.988 billion U.S. dollars. However, with the further development of the market globalization and the shift of the world’s raw material drug production center to Asia, the competition in the international market for raw material drug sales has become increasingly fierce. The Chinese raw material drug manufacturers will face even more severe tests. Rely on the traditional system of outsourcing of foreign trade can not make the domestic API manufacturers to succeed in the international competition. Under the traditional underwriting of foreign trade, although the products of some enterprises have been exported for a long time, the enterprises themselves do not understand how their products operate in the international market and, of course, not to mention the establishment of enterprises in the international market